Home › Therapeutic areas › Neurology › Non-24-Hour Sleep-Wake Disorder

Non-24-Hour Sleep-Wake Disorder (1 companies)

Companies with an active program in Non-24-Hour Sleep-Wake Disorder.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
VNDA Vanda Pharmaceuticals CardiovascularDermatology+6 Rare 1 Approved $231M 27